E Fund Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

E Fund Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-223,808	Closed	-$198K	–	358
2022 Q4	$198K	Buy	223,808 +22,818	+11%	+$30.3K	0.02%	305
2022 Q3	$316K	Buy	200,990 +4,717	+2%	+$10.7K	0.03%	228
2022 Q2	$395K	Buy	196,273 +73,225	+60%	+$127K	0.04%	190
2022 Q1	$287K	Buy	123,048 +95,216	+342%	+$297K	0.01%	210
2021 Q4	$129K	Buy	27,832 +6,068	+28%	+$37.7K	﹤0.01%	281
2021 Q3	$166K	Buy	+21,764	New	+$185K	0.01%	241
2021 Q1	$112K	Buy	+13,528	New	+$143K	0.01%	237

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return